Amylyx Pharmaceuticals (AMLX) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -74.8 | -179.9 | 11.9 | -167.6 | -123.3 | -120.4 | ||
| Changes by years, y/y, % | +104% | +140% | -107% | -1 507% | -26% | +27.4% | |||
Amylyx Pharmaceuticals. OCF, bln rub
Amylyx Pharmaceuticals. OCF, changes, %
Amylyx Pharmaceuticals. OCF, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) OCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OCF, bln rub | ? | -39.8 | -25.2 | -30.4 | -27.9 | -36.9 | -120.4 | |
| Changes by years, y/y, % | +8 044% | -62% | -27% | -53% | -7% | |||
| Changes by quarters, q/q, % | -33% | -37% | +20% | -8% | +32% | |||